Max Healthcare Institute Ltd.’s gross revenue in Q3FY23 rose 13% to ₹ 1,559 crores. Consolidated Profit After Tax came at ₹ 269 crores showcasing a 7% rise YoY over the corresponding period. In this quarter’s results, the reports suggested that the firm has continued to deliver consistent performance in all key operational and financial indicators in Q3Y23.
Max Healthcare Q3FY23; 7% Growth in Profits
Tags: Healthcare
Related Post
- Natco Pharma Ltd Q2FY25; 83% rise in Profits
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged…
-
Muthoot Finance Ltd Q2FY25; 26% rise in Profits
Muthoot Finance is NBFC engaged in the business of providing gold loans. The company predominately…
-
Multi Commodity Exchange of India Ltd Q2FY25; 73% rise in Revenue
The MCX commenced operation in Nov,03 is India’s first listed, national-level, electronic exchange, and India’s…